Canadian pharmacists say a shortage of medications that contain oxycodone is expected to continue into the new year, while ...

Manufacturer has indicated some supply will be available in December, though there will be constraints because of backorders ...

Pharmacists say a shortage of medications that contain oxycodone is expected to continue into the new year, while supply of ...

Pharmacists say a shortage of some prescription painkillers is expected to continue as alternatives have seen an increase ...

Shortages of some prescription painkillers are expected to continue for a few months in Canada. In July, Health Canada announced a shortage of drugs that contain acetaminophen with oxycodone, ...

Marijuana products remain federally illegal until approved by the FDA, and only three cannabis-based drugs have received ...

The consumer products giant reached a $40 billion deal to buy Kenvue, the maker of Tylenol, despite a barrage of unproven ...

Kimberly-Clark is buying Tylenol maker Kenvue in an approximately $48.7 billion cash-and-stock deal, creating a massive ...

Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer health goods company. Shareholders of Kimberly-Clark will own about 54% of ...

WASHINGTON — President Donald Trump isn't a doctor. But he played one on TV Monday, offering copious amounts of unproven medical advice that he suggested — often without providing evidence — could ...

Kenvue is under scrutiny after the Trump administration linked Tylenol to autism. Merger aims for $32 billion in annual revenue and $7 billion operating profit. The deal is expected to close in the ...